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Abstract
Background: The aim of our study was to objectively compare Cytyc Thinprep® and other
methods of obtaining thin layer cytologic preparations (cytocentrifugation, direct smearing and
Millipore® filtration) in urine cytopathology.
Methods: Thinprep slides were compared to direct smears in 79 cases. Cytocentrifugation carried
out with the Thermo Shandon Cytospin® 4 was compared to Thinprep in 106 cases, and
comparison with Millipore filtration followed by blotting was obtained in 22 cases. Quality was
assessed by scoring cellularity, fixation, red blood cells, leukocytes and nuclear abnormalities.
Results:  T h e  d a t a  s h o w  t h a t  1 )  s m e a r i n g  a l l o w s  good overall results to be obtained, 2)
Cytocentrifugation with reusable TPX® chambers should be avoided, 3) Cytocentrifugation using
disposable chambers (Cytofunnels® or Megafunnel® chambers) gives excellent results equalling or
surpassing Thinprep and 4) Millipore filtration should be avoided, owing to its poor global quality.
Despite differences in quality, the techniques studied have no impact on the diagnostic accuracy as
evaluated by the rate of abnormalities.
Conclusion: We conclude that conventional methods such as cytocentrifugation remain the most
appropriate ones for current treatment of urinary samples. Cytyc Thinprep processing, owing to
its cost, could be used essentially for cytology-based molecular studies.
Background
More than 50,000 new cases of urothelial carcinoma,
which represents 90% of bladder cancer cases are diag-
nosed annually in Europe and in North America [1].
About 70% of bladder urothelial carcinomas are superfi-
cial (TNM stage pTa-1) and may be viewed, diagnosed and
treated by cystoscopy aided by biopsies and transurethral
resection [2].
Despite it is recognized as the biological standard for the
diagnosis and follow up of bladder tumors, urinary cytol-
ogy has a mean sensitivity of about 50% and it is ham-
pered by a large amount of non-diagnostic samples [3].
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Although urinary cytology detects about 80% of aggres-
sive, high grade (G3) urothelial tumors, some results
remain falsely negative, particularly in patients having
had TUR or bacillus Calmette-Guérin immunotherapy. In
urology practice, cystoscopy is commonly combined with
urinary cytology, particularly in the search for high grade
wherever its location in the urinary tract.
Liquid-based cytology (LBC) has been developed as a
replacement to cytocentrifugation and/or smearing,
owing to cell recovery capabilities and better cell preserva-
tion. Some LBC methods use a filtration process and a
computer-assisted thin-layer deposition of cells (Cytyc
Thinprep® supplied by Cytyc Corp., Boxborough, MA),
whereas others are based on a sedimentation process
(AutoCyte® PREP supplied by TRiPath Imaging, Burling-
ton, NC). In the urine, the use of Cytyc Thinprep 2000
results in increased cellularity and marked reduction of
debris, red blood cells (RBC) and crystals [4-7].
However, optimization of cell capture and fixation as well
as thin-layer deposition of cells can be achieved by other
methods than LBC, particularly while using modern cyto-
centrifugation methods [7]. In our experience based on
2500 specimens/year for 15 years, and provided specific
requirements are followed, direct smears and cytocentrif-
ugation with the Shandon Cytospin® 4 (Thermo Electron
Corp., Waltham, MA) produce highly satisfying cytologi-
cal specimens.
Accordingly, the aim of our study was 1) to objectively
analyze the quality of urine samples processed by a body
of conventional thin-layer methods as compared with
Cytyc Thinprep LBC and 2) to verify if differences noted
have an impact on diagnostic accuracy.
Methods
The study population was composed of 224 urine samples
taken in patients with symptoms suggesting bladder can-
cer (gross hematuria, micturition disorders, chronic uri-
nary infection) in 89 cases (39.7%), or followed after
transurethral resection for bladder urothelial carcinoma
in 135 cases (60.3%).
Urinary samples were taken after cystoscopy in 157 cases
(63.8%), and after simple micturition in other cases. All
samples were immediately fixed with 50% ethanol (V/V)
or with a 20% Polyethyleneglycol 1500 (Merck, Darm-
stadt, Germany) solution in 50% ethanol (1/3 fixative
and 2/3 urine).
Urine samples were sent to the laboratory and separated
into two aliquots after homogeneization. One of the aliq-
uots was processed according to the Thinprep LBC recom-
mendations, and the other was processed according to a
smear method, by cytocentrifugation or by filtration.
Cytyc Thinprep* processing
The Thinprep 2000 automaton allows thin-layer cell prep-
arations to be provided thanks to a filtration process: after
the TransCyt® filter has been plunged into the sample, it
rotates at a high speed and facilitates cell and mucus dis-
persion. A vacuum is then applied to the filter, which col-
lects cells on a 5 µm porosity membrane. A software
program allows a homogeneous deposition of cells until
saturation. The TransCyt filter is then inverted and a posi-
tive pressure allows cells to adhere to an electronegative
slide. After insertion of another TransCyt filter and of
another slide, the whole procedure may be repeated until
the entire sample has been treated.
The urine samples studied were processed according to
instructions for non mucoid fluids: samples were mixed
with a Cytolyt® solution containing methanol, mucolytic
and hemolytic agents and were then centrifuged at 600 G
for 10 minutes. After discarding the supernatant, the cell
pellet was mixed with a PreservCyt® solution and treated
by the Thinprep 2000 processor. Thinprep slides were
used in all cases.
Smearing on coated slides
Comparison of LBC with smears was made in 79 cases.
After centrifugation at 600 G for 10 minutes and careful
removing of the supernatant, the cell pellet was aspirated
and smeared on a thin coating layer (Glycerin/Albumin
according to Mallory, Bayer Diagnostics, Puteaux, France)
previously deposited on two Superfrost® Plus slides (Men-
zel-Gläser, Braunschweig, Germany). Slides were immedi-
ately fixed with a Cell-Fixx®  (Thermo Electron Corp.,
Waltham, MA) spray and allowed to dessicate at room
temperature (RT) for at least 1 hour before Papanicolaou
staining.
Cytocentrifugation methods
Comparison of LBC with cytocentrifugation was made
using the Thermo Shandon Cytospin® 4 in 106 cases. After
centrifugation at 600 G for 10 minutes, hypocellular urine
samples (< 20 µl cell pellets) were cytocentrifuged with
sample chambers up to 0.5 ml. Conversely, urine samples
with a large pellet were treated with large volume sample
chambers.
The Cytospin system uses centrifugation and fluid absorp-
tion principles and allows deposition of a thin layer of
cells on round or rectangular areas. The deposition proc-
ess needs that sample chambers are placed and locked
into stainless steel Cytoclip® assembly devices. In order to
test various types and qualities of sample chambers we
used:BMC Clinical Pathology 2005, 5:9 http://www.biomedcentral.com/1472-6890/5/9
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1) three years' old round reusable, autoclavable chambers
designed for samples up to 0.5 ml (TPX® chambers with a
cell deposition area of 6 mm diameter, allowing 28 mm2
to be screened) in 44 cases,
2) round disposable chambers designed for samples up to
0.5 ml (single Cytofunnel® with a cell deposition area of 6
mm diameter, allowing 28 mm2 to be screened) in 31
cases,
3) large volume disposable chambers designed for sam-
ples up to 6 ml (Megafunnel® chambers with a cell depo-
sition area of 21 × 24 mm, allowing 294 mm2 to be
screened) in 31 cases.
Two slides of 28 mm2 screening area (for 1 ml of urine),
and one slide of 294 mm2 screening area (for 6 ml of
urine) were prepared for each specimen studied.
Specially marked coated Cytoslides® provided by Thermo
Shandon were used. Although not necessary, slides proc-
essed with TPX sample chambers had an additional treat-
ment with a drop of glycerine/albumin deposited on the
sample area.
Millipore filtration methods
LBC was compared with Millipore filtration followed by
blotting of cells on various slides in 39 cases, in order to
test the adhesiveness to various types of commercially
available coated slides. Urine was filtered through Magna®
MCE nitrocellulose membrane filters, pore size 5 µm,
diameter 25 mm placed in a Swinnex® device attached to
a 60 ml Luer-Lock® syringe (Bioblock Scientific, Illkirch,
France).
After complete filtration and removal of the membrane
filter, the blotting was first performed on Polysine® slides
(Menzel-Gläser, Braunschweig, Germany) in 8 cases, but
the adhesiveness obtained was too impaired for allowing
continuation of the assays. We then used Cytyc Thinprep
slides in 9 cases, but finally we chose Superfrost® Plus
slides and Snowcoat X-tra® slides (Surgipath Europe Ltd,
Peterborough, England) equally for the 22 remaining
cases.
Using these procedures, the resulting cell deposition area
is 25 mm diameter, allowing about 491 mm2  to be
screened.
Smears were stained with a hypochromic Papanicolaou
stain [8] before analysis.
Analysis of morphologic criteria
A single pathologist (EP) compared conventional and
LBC slides using an Olympus BHS microscope. Slides
were placed side by side and were analyzed under Plan ×
10, Plan × 40 and Oil PlanApo x63 objectives. The global
quality of slides was assessed by scoring cellularity, cell
Comparison of smears versus Thinprep slides (mean values,  standard deviations and statistical significance) Figure 1
Comparison of smears versus Thinprep slides (mean values, 
standard deviations and statistical significance).
Comparison of cytocentrifugation using reusable TPX cham- bers versus Thinprep slides (mean values, standard deviations  and statistical significance) Figure 2
Comparison of cytocentrifugation using reusable TPX cham-
bers versus Thinprep slides (mean values, standard deviations 
and statistical significance).BMC Clinical Pathology 2005, 5:9 http://www.biomedcentral.com/1472-6890/5/9
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fixation, number of RBC, leukocytes and degenerative
changes of urothelial cells. The presence of cell groups and
clusters was also measured. Special attention was paid to
altered cellular features potentially indicating malignant
transformation – increased N/C ratio, nuclear hyperchro-
matism, irregular nuclear shape, prominent nucleoli and
mitoses – as previously described [9].
All cellular features were coded from 0 to xxx according to
their degree of abnormality.
Urothelial cells were recognized as malignant, high-grade,
when they showed increased N/C ratio, nuclear hyper-
chromatism and markedly irregular nuclear borders or
prominent nucleoli. They were recognized as neoplastic,
low-grade, when they formed papillary fronds demon-
strating increased N/C ratio and slightly irregular nuclear
shape, or where numerous elongated cells with slight
nuclear abnormalities could be evidenced, as described in
the literature [9,10].
Cytological results were categorized as positive or negative
for urothelial tumor cells, whatever their grade. Normal,
inflammatory, reactive and degenerative conditions of
urothelial cells were considered as negative, as well as
urothelial atypias of undetermined significance.
Numerical data were analyzed using paired series Chi-
square test or Fisher's exact test, when appropriate, and a
probability level of 0.05 was regarded as significant.
Results
Using the scoring system as described in the Materials and
Methods section, and considering a 0–3 scale, mean and
standard deviations as well as the statistical significance of
each parameter are shown in Figure 1,2, 3, 4, 5.
Differences noted concern global quality (cellularity and
fixation combined) on the one hand, number of RBC and
leukocytes on the other hand. Surprisingly, we found that
smears allowed obtaining a global quality superimposa-
ble to that of Cytyc Thinprep slides (Figure 6). More pre-
cisely, the cellularity scores obtained by smears and LBC
were 1.97 ± 0.86 versus 1.96 ± 0.68, respectively (p = ns),
whereas values for fixation were 2.58 ± 0.48 versus 2.50 ±
0.59 (p = ns).
Cytocentrifugation with 3 years' old reusable sample
chambers resulted in significant decrease in both cellular-
ity and fixation quality, whereas cytocentrifugation with
disposable sample chambers (whatever the type of cham-
ber used) allowed obtaining the better results (Figure 7).
Comparison of cytocentrifugation using disposable Cytofun- nels (for samples up to 0.5 ml) versus Thinprep slides (mean  values, standard deviations and statistical significance) Figure 3
Comparison of cytocentrifugation using disposable Cytofun-
nels (for samples up to 0.5 ml) versus Thinprep slides (mean 
values, standard deviations and statistical significance).
Comparison of cytocentrifugation using disposable Megafun- nels (for samples up to 6 ml) versus Thinprep slides (mean  values, standard deviations and statistical significance) Figure 4
Comparison of cytocentrifugation using disposable Megafun-
nels (for samples up to 6 ml) versus Thinprep slides (mean 
values, standard deviations and statistical significance).BMC Clinical Pathology 2005, 5:9 http://www.biomedcentral.com/1472-6890/5/9
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Millipore filtration resulted in impaired cell preservation
even after blotting of cells on coated slides and careful
fixation.
The concentration of RBC was significantly decreased after
LBC treatment of samples in all circumstances except in
Millipore* filtration using 5 µm porosity membranes.
Similar comments may be done about leukocytes.
Whatever the technique studied, the search for cell groups
and atypias gave results identical than those of LBC except
for smears which showed a slightly higher percentage (p =
0.01). However, the values obtained were not strikingly
different.
Discussion
As far back as the late 'seventies, authors have attempted
to compare cytocentrifugation with other methods such
as filtration [11,12]. In those preliminary studies, Milli-
pore filtration was found to give better cell recovery and
better morphologic details than cytocentrifugation. How-
ever the methods used (reusable sample chambers) was
suboptimal: a significant cell loss can be attributed to the
roughness of sample chamber walls secondary to repeated
cleaning [13].
Waiting the 'nineties was necessary for obtaining compar-
isons between the Cytyc Thinprep LBC and other meth-
ods, with some contradictory results. Many of the studies,
published as abstracts of the 40th and 41st Annual Scien-
tific Meetings of the International Academy of Cytology,
were not transformed into full length articles [4,5,14,15].
Except for one study which showed processing time and
cost several times greater for Cytyc Thinprep LBC than for
polycarbonate membrane filtration [15], most series rec-
ognize advantages in using LBC. In a recent study compar-
ing cytocentrifugation to Cytyc Thinprep, Cytospin
preparations were found superior to LBC in terms of cyto-
morphologic details and preservation of architectural
patterns [16]. However the advantage of LBC concerning
cleaner background was noted.
Cytocentrifugation and LBC are not the only available
methods for improving diagnostic accuracy: potentially
interesting results were previously shown by Albright and
Frost [17]. Using a simple density gradient to separate
atypical cells from normal cells after fixation with the Sac-
comanno method, the authors were able to enrich up to
20-fold the atypical and cancer cell fraction. To our
knowledge however, these results have not been resumed
at a later date.
A more recent study assessed the quality and cost of Auto-
Cyte PREP versus cytocentrifugation of urine specimens in
a general laboratory setting [18]. It was shown that the
Cytospin method, despite longer preparation time, had 1)
shorter screening time, 2) higher number of diagnostic
cells, 3) better fixation and staining quality than the Auto-
Cyte PREP. Additionally, the Cytospin method was found
7 times less expensive than the AutoCyte* PREP method.
Concerning conventional methods, the values obtained
in our series show that despite differences in quality, the
techniques studied have no impact on the diagnostic
accuracy as evaluated by the rate of abnormalities (nuclear
features and cell groups). About each technique studied,
the following comments may be done:
1. Smearing allows obtaining good overall results for the
lowest cost. However the longer screening time renders
the method suboptimal. Additionally the glycerine/albu-
min coating used renders slides useless for immunocyto-
chemistry or other molecular studies,
2. Cytocentrifugation with reusable chambers should be
avoided if annual renewal cannot be guaranteed,
3. Millipore filtration followed by blotting of cells on
coated slides should be avoided, owing to poor global
quality and high cost,
4. Cytocentrifugation using disposable chambers (Cyto-
funnels or Megafunnel chambers) gives excellent results
Comparison of Millipore filtration followed by blotting of  cells on coated slides versus Thinprep slides (mean values,  standard deviations and statistical significance) Figure 5
Comparison of Millipore filtration followed by blotting of 
cells on coated slides versus Thinprep slides (mean values, 
standard deviations and statistical significance).BMC Clinical Pathology 2005, 5:9 http://www.biomedcentral.com/1472-6890/5/9
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equalling or surpassing LBC if one considers cellularity,
fixation and the comfort for screening.
Concerning cost-efficacy comparisons, it has been shown
that the monthly cost of the two most efficient methods
(Cytocentrifugation with disposable chambers and Cytyc
Thinprep LBC) is strikingly different: there is a 92.8% to
154.5% increased cost for LBC versus cytocentrifugation
with disposable Megafunnels and Cytofunnels, respec-
tively [19].
However in our opinion, one must consider not only the
diagnostic performance and cost, but also the ultimate
goal of technical improvements provided by LBC. LBC
aims primarily to provide reproducible and well preserved
material for additional techniques such as immunocyto-
chemistry, fluorescence in situ hybridization (FISH) and
other types of molecular analyses. It has been shown that
Thinprep-processed samples allowed efficient recovery of
the DNA, RNA and proteins related to the p53 tumor sup-
pressor gene [20].
Conclusion
We conclude that Cytyc Thinprep LBC, despite its cost,
may still be considered as a technical progress for
cytology-based molecular studies. To an economical
point of view and taking into account the value of a metic-
ulous technique, cytocentrifugation with disposable
chambers remains the technical standard for current treat-
ment of urinary samples.
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